Abstract
Background: Most of the chemical substances which emerge out as potential drug candidates (Active Pharmaceutical Ingredients) are either weak acids or weak bases. The poor aqueous solubility of these drug substances is a common concern. Several R&D centers are focused on developing suitable, economic, simpler and more feasible solubility enhancement techniques for increasing the solubility and thereby bioavailability of such drug substances. Nanocrystals are one of the preferred approaches for solubility enhancement in the last few decades.
Methods: Nanocrystal as a solubility enhancement approach is widely explored and discussed by many researchers. Despite being the most simple and feasible technique, nanocrystal formulation has its own limitations. The present review enlightens some novel technologies which can overcome disadvantages of conventionally well-established bottom-up and top-down techniques used for nanocrystal formulation. Results/Applications: The present review summarizes and also highlights the correlation between some novel findings like reduction in the melting point of drug and nanocrystal formulation. The review also includes a special section emphasizing on the patents granted in the field of nanocrystals. The review includes more than ten patents focusing on several aspects of nanocrystal formulations as manufacturing methods, formulation components and conventional and novel applications of nanocrystals in new and hybrid forms. Aspects related to advantages of nanocrystals over other formulation approaches, targeting (Active and Passive) through nanocrystal formulations and issues related to nanotoxicity are also reviewed and discussed in the present article. Conclusion: The findings, research outcomes and patents related to nanocrystal formulations, reported in the present review confirm the potential of the stated system as a drug delivery tool. The review emphasizes on the urge for further exploration required in the area of nanocrystal system for enhancing its efficiency as a drug delivery and a diagnostic tool.Keywords: Bioavailability enhancement, drug targeting, nanocrystals, nanotoxicity, quantum dots, solubility enhancement.
Graphical Abstract
Recent Patents on Nanotechnology
Title:Nanocrystal Based Drug Delivery System: Conventional and Current Scenario
Volume: 11 Issue: 2
Author(s): Shreya Thakkar*, Viral Shah*, Manju Misra and Kiran Kalia
Affiliation:
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad,India
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad,India
Keywords: Bioavailability enhancement, drug targeting, nanocrystals, nanotoxicity, quantum dots, solubility enhancement.
Abstract: Background: Most of the chemical substances which emerge out as potential drug candidates (Active Pharmaceutical Ingredients) are either weak acids or weak bases. The poor aqueous solubility of these drug substances is a common concern. Several R&D centers are focused on developing suitable, economic, simpler and more feasible solubility enhancement techniques for increasing the solubility and thereby bioavailability of such drug substances. Nanocrystals are one of the preferred approaches for solubility enhancement in the last few decades.
Methods: Nanocrystal as a solubility enhancement approach is widely explored and discussed by many researchers. Despite being the most simple and feasible technique, nanocrystal formulation has its own limitations. The present review enlightens some novel technologies which can overcome disadvantages of conventionally well-established bottom-up and top-down techniques used for nanocrystal formulation. Results/Applications: The present review summarizes and also highlights the correlation between some novel findings like reduction in the melting point of drug and nanocrystal formulation. The review also includes a special section emphasizing on the patents granted in the field of nanocrystals. The review includes more than ten patents focusing on several aspects of nanocrystal formulations as manufacturing methods, formulation components and conventional and novel applications of nanocrystals in new and hybrid forms. Aspects related to advantages of nanocrystals over other formulation approaches, targeting (Active and Passive) through nanocrystal formulations and issues related to nanotoxicity are also reviewed and discussed in the present article. Conclusion: The findings, research outcomes and patents related to nanocrystal formulations, reported in the present review confirm the potential of the stated system as a drug delivery tool. The review emphasizes on the urge for further exploration required in the area of nanocrystal system for enhancing its efficiency as a drug delivery and a diagnostic tool.Export Options
About this article
Cite this article as:
Thakkar Shreya*, Shah Viral*, Misra Manju and Kalia Kiran , Nanocrystal Based Drug Delivery System: Conventional and Current Scenario, Recent Patents on Nanotechnology 2017; 11 (2) . https://dx.doi.org/10.2174/1872210510666161014122439
DOI https://dx.doi.org/10.2174/1872210510666161014122439 |
Print ISSN 1872-2105 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4020 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting the p53-Family in Cancer and Chemosensitivity: Triple Threat
Current Drug Targets Sleep Disturbances in Lung Cancer Patients
Current Respiratory Medicine Reviews Pisosterol Induces G2/M Cell Cycle Arrest and Apoptosis via the ATM/ATR Signaling Pathway in Human Glioma Cells
Anti-Cancer Agents in Medicinal Chemistry Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer
Recent Patents on Anti-Cancer Drug Discovery In-Silico Algorithms for the Screening of Possible microRNA Binding Sites and Their Interactions
Current Genomics Targeted Therapies for Non-Small Cell Lung Cancer
Current Pharmaceutical Design A Review on the Phytochemicals, Ethnomedicine Uses and Pharmacology of Ficus Species
Current Traditional Medicine Mucoadhesive Chitosan Derivatives as Novel Drug Carriers
Current Pharmaceutical Design Reversal of Tumor Induced Dendritic Cell Paralysis: A Treatment Regimen Against Cancer
Current Immunology Reviews (Discontinued) Hepatic MicroRNA Orchestra: A New Diagnostic, Prognostic and Theranostic Tool for Hepatocarcinogenesis
Mini-Reviews in Medicinal Chemistry Chemical and Potential Biological Perspectives of Genus Sarcococca (Buxaceae)
The Natural Products Journal Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
Current Medicinal Chemistry Lessons from Viruses: Controlling the Function of Transmembrane Proteins by Interfering Transmembrane Helices
Current Medicinal Chemistry Double-Edged Effects of Arsenic Compounds: Anticancer and Carcinogenic Effects
Current Drug Metabolism FBP1, A Tumor Suppressor and Negative Regulator of Glycolysis, was Epigenetically Silenced in Pancreatic Cancer
Current Signal Transduction Therapy Bonafide Targets of Deregulated microRNAs in Non-Small Cell Lung Cancer as Tool to Identify Novel Therapeutic Targets: A Review
Current Pharmaceutical Design Effects of Natural Compounds on Xenopus Embryogenesis: A Potential Read Out for Functional Drug Discovery Targeting Wnt/β-catenin Signaling
Current Topics in Medicinal Chemistry Evaluation of Angiogenesis with the Expression of VEGF-C and CD34 in Human Colon Cancer
Current Chemical Biology Low Activity of Plasminogen Activator: A Common Feature of Non- Iatrogenic Comorbidities of Schizophrenia
CNS & Neurological Disorders - Drug Targets A Steroidal Na<sup>+</sup>/K<sup>+</sup> ATPase Inhibitor Triggers Pro-apoptotic Signaling and Induces Apoptosis in Prostate and Lung Tumor Cells
Anti-Cancer Agents in Medicinal Chemistry